Clinical Continuity When a Healthcare Organization Changes

By Kanwar Partap Singh Gill, MD · Family medicine physician · 5 November 2026

• Transitions are where clinical tasks get dropped
• The physician's question
• A pharmacy changeover
• When the EHR changes
• Handoffs between people, not only systems
• Five groups of active work
• Downtime and recovery
• Organizational responsibilities
• How the review proceeds
• After the change: a clinical lookback
• Evidence that a transition is well prepared
• Before the contract is signed
• Where the clinical review stops
• What a review of this issue can deliver

Transitions are where clinical tasks get dropped

Every healthcare organization carries a load of unfinished clinical work: results not yet reviewed, referrals not yet scheduled, prescriptions mid-refill, patients due for a recheck next week. On an ordinary day that work moves through familiar routes. When a pharmacy vendor, EHR, facility operator, management company or care contract changes, the routes change too, and tasks that belonged to everyone in the old arrangement can belong to no one in the new one.

Those tasks seldom appear in a transaction's documents. A services agreement describes coverage hours and response times; it rarely lists the dozens of abnormal results that may sit in a departing clinician's queue.

The physician's question

A clinical continuity review asks two things: which active care obligations need to survive the change, and what evidence will show that each remains assigned and actionable. Lawyers, accountants, technical specialists and operators address their own questions about the transition. The medical review connects the transition to patient care, and keeps its own scope clear.

A pharmacy changeover

A successful pharmacy transition preserves the clinically necessary functions (supply, special formulations, pending clarifications, monitoring triggers, and a route for urgent problems) and makes responsibility for each one clear. A matching list is evidence of data transfer, not of continuity.

When the EHR changes

An EHR migration poses the same problem in a different form. A document may remain available as a scanned file while a pending-result queue, a referral's status or a medication instruction behaves differently in the new workflow. An outside report filed under one heading in the old system may land under another, or arrive as an image that no rule routes to anyone. The presence of data alone does not show that the relevant task will reach the right person.

The review therefore examines what users can see and do in the implemented process, not what the migration plan says will be available. A test that asks "is the result in the new system?" is different from one that asks "will the clinician responsible for this patient be prompted to act on it?"

The same structure appears in result queues mapped to a generic pool, recall lists that do not migrate as active tasks, and standing orders that import as text rather than as orders. A clinical reviewer cannot validate a data migration, but can identify which clinical states have to survive it and design the checks that would show whether they did.

Handoffs between people, not only systems

Some transitions change the clinicians rather than the software. When a medical group's contract ends, or a management company replaces staff, the departing clinicians take with them a layer of knowledge the record never captured: the patient who was to be called personally when a biopsy returned, the family member who is the only reliable contact, the dose that was being adjusted week by week. Their inboxes may hold unsigned notes, pending cosignatures and results acknowledged but not yet acted on.

The review asks how each departing clinician's open work was identified and reassigned, whether incoming clinicians received a handoff for patients with time-sensitive plans, and whether unsigned or incomplete documentation was resolved before access ended. A list of patients is not a handoff; a handoff carries the pending decision and the reason it matters.

Five groups of active work

A focused review can begin with five groups of clinical work. For each group, it asks the same set of questions.

The answers become a transition risk register: each task, its current and proposed owner, the evidence that ownership has transferred, and the gaps where it has not.

Downtime and recovery

Every transition carries a period when one system is going down and the other is not yet fully trusted. ONC's SAFER Guide on Contingency Planning addresses how organizations prepare for EHR downtime and recover from it. From a clinical standpoint, the questions are concrete: during the gap, how are current medication lists obtained, how do urgent results reach a clinician, how are orders and notes recorded, and who reconciles the paper or interim record into the new system afterward? A clinic that cannot answer those questions before cutover is likely to discover the answers during it.

Organizational responsibilities

ONC's SAFER Guide on Organizational Responsibilities addresses the people and processes an organization needs for safe EHR use. A change in operator or management raises a related clinical question: after the change, who holds clinical decision authority? Who can approve an outside referral, authorize a non-formulary medication, or override a routine process when a patient's condition requires it? If that authority moved, did the information needed to exercise it move with it? The physician maps these clinical decision points; counsel addresses the corporate and contractual authority behind them.

How the review proceeds

1. Define the change. Which services, systems, sites and dates are affected, and which clinical functions the organization expects to continue unchanged.
2. Inventory open work. Using the five groups, identify the categories of active clinical tasks and how many items each holds on a given date.
3. Trace sample items end to end. Follow selected items from each group through the proposed or implemented process, from the triggering event to the clinician who must act and the confirmation that the action happened.
4. Test the urgent route. Walk through what happens to an urgent problem at the least favorable time, such as a critical result late on a Saturday during the first weekend after cutover.
5. Report findings with their evidence. State which handoffs are supported by evidence, which are assumed, and which are unassigned, with the records that would resolve each.

This is a practical working sequence, not a validated audit instrument. Its scope is set by the question the organization brings, and a narrow review of one queue or one pharmacy changeover is often more useful than a broad one.

After the change: a clinical lookback

When a transition has already happened and something was dropped, the clinical questions shift. Which categories of patients could have been affected? How should they be prioritized, by clinical risk rather than by the order they appear in a report? Who reviews each one, and how is the review documented so that the organization can show what it found and what it did? A physician can help design that lookback and the criteria for escalating individual patients, while counsel addresses any notification or reporting obligations.

Evidence that a transition is well prepared

The review is not a search for failure. A verified medication reconciliation, a named clinician responsible for each queue, a tested escalation route, a downtime fallback rehearsed before go-live, and a planned lookback after cutover all support a favorable assessment, and the report states that plainly. Organizational change is not harmful by default; the purpose is to identify what the evidence supports.

Before the contract is signed

The same method can inform a purchaser's clinical questions before an agreement is final. A commitment to "provide follow-up care" or "ensure medication continuity" becomes meaningful when its process is described: who identifies the need, who arranges the care, who monitors completion, and who acts if the first attempt fails. A county, health plan, facility or practice buying clinical services can ask for that description, and the physician can identify which clinical questions remain unanswered without interpreting the contract's legal effect.

Where the clinical review stops

What a review of this issue can deliver

A clinical continuity assessment: a transition risk register organized by the five groups of active work, an evidence request identifying what would confirm each handoff, and a short set of actions for the organization to consider before and after the change. This work is described under Clinical Governance and Care Delivery Review, with medication-specific questions covered in Medication Continuity and Transitions of Care. The full set of consulting services is listed on the Clinical Consulting page.